Please login to the form below

Not currently logged in
Email:
Password:

Fluarix Quadrivalent

This page shows the latest Fluarix Quadrivalent news and features for those working in and with pharma, biotech and healthcare.

GSK gets OK for second quadrivalent flu vaccine in US

GSK gets OK for second quadrivalent flu vaccine in US

GSK joined the club when its Fluarix Quadrivalent was approved by the FDA last December, and since then Sanofi has also been given a green light for its Fluzone Quadrivalent, giving ... This year the WHO also made recommendations for quadrivalent

Latest news

  • FDA approves Sanofi's four-in-one flu vaccine FDA approves Sanofi's four-in-one flu vaccine

    It becomes the third major four-strain influenza vaccine approved in the US following FDA backing for AstraZeneca's FluMist Quadrivalent in March 2012 and GlaxoSmithKline's (GSK) Fluarix Quadrivalent nine ... which is approved in people aged two to 49,

  • GSK’s four-strain flu vaccine approved in Germany and UK GSK’s four-strain flu vaccine approved in Germany and UK

    Will be sold as Influsplit Tetra in Germany and Fluarix Tetra in the UK. ... GSK launched its four-strain version in the US last December under the Fluarix Quadrivalent name, and with AstraZeneca/Medimmune's FluMist Quadrivalent already on the market,

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics